Search Results
Archive
… 2001: FDA Approves Genetics-based Drug to Treat Leukemia …
Archive
… Researchers Identify Potential Drug Targets Markers For Leukemia Risk …
The Informed Consent Resource
Explore genomics-relevant considerations for informed consent and guidance on how to approach them.
… capacity. Additionally, people who have suffered an acute injury may be unable to consent. As with any research, …
Research Funding
The following are research areas of interest that have been identified by the participating NIH institutes, centers, and offices (ICOs) on the investigator-initiated ELSI Research Grants (R01, R21, R03). Program Officer(s) contact information is also included for each ICO.
… biomarkers to risk for OUD how do we use it clinically for acute pain and/or chronic pain? What are the potential …
File
… CCR5; CCR2; IL-10 Leprosy HLA-DR Hepatitis-B HLA-DR; IL-10 Acute bacterial infection MBL-2; FC γRII-R; Sec 2 G6PD : … gers of inequitable commercial exploitation are even more acute. Box 6.1 (continued) will remain the property of Tonga …
About NHGRI
A timeline of notable events in the history of the National Human Genome Research Institute.
… world expert in the onset, development and progression of leukemia, Dr. Liu leads the Oncogenesis and Development …
Research at NHGRI
A list of publications led by or in collaboration with the Center for Research on Genomics and Global Health.
… analysis suggests clues about genetic susceptibility. Leukemia . 35(4):1224. 2021. Erratum for: Leukemia . 35(4):1209-1213. 2021. [ PubMed ]  Rotimi CN , … analysis suggests clues about genetic susceptibility. Leukemia . 2020. [ PubMed ] Choudhury A, Aron S, Botigué LR, …